SPTS 📈 SPDR Barclays Short Term - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78468R1014 • Short Government

SPTS: U.S. Treasury, Short-Term, Government, Bonds, Securities

The SPDR Barclays Short Term Treasury ETF, listed on NYSE ARCA under the ticker SPTS, is designed to track the performance of short-term U.S. Treasury obligations with maturities ranging from 1 to 3 years. By investing at least 80% of its total assets in securities that comprise the index or have substantially identical economic characteristics, the fund aims to provide investors with exposure to the short-term Treasury market. This strategy allows the fund to maintain a high level of correlation with the underlying index, which is specifically designed to measure the performance of short-term public obligations of the U.S. Treasury.

The fund's investment approach is focused on replicating the index's performance, which is comprised of U.S. Treasury securities with short-term maturities. The index is designed to provide a representative sample of the short-term Treasury market, allowing investors to gain exposure to this specific segment of the fixed income market. With its ETF structure, the SPDR Barclays Short Term Treasury ETF offers investors the benefits of transparency, liquidity, and diversification, making it an attractive option for those seeking to allocate a portion of their portfolio to short-term U.S. Treasury securities. The fund's domicile is in the United States, and its ISIN is US78468R1014, categorizing it as a short government ETF.

As a short government ETF, the SPDR Barclays Short Term Treasury ETF is designed to provide investors with a low-risk investment option that tracks the performance of short-term U.S. Treasury securities. The fund's portfolio is composed of securities with high credit quality, as they are backed by the full faith and credit of the U.S. government. This makes the fund an attractive option for investors seeking to manage their interest rate risk or maintain a low-risk profile in their portfolio. With its transparent and rules-based investment approach, the SPDR Barclays Short Term Treasury ETF offers investors a convenient and efficient way to gain exposure to the short-term Treasury market.

Additional Sources for SPTS ETF

SPTS ETF Overview

Market Cap in USD 5,577m
Category Short Government
TER 0.03%
IPO / Inception 2011-11-30

SPTS ETF Ratings

Growth 5y 24.7%
Fundamental -
Dividend 63.9%
Rel. Strength Industry 154
Analysts -
Fair Price Momentum 27.49 USD
Fair Price DCF -

SPTS Dividends

Dividend Yield 12m 3.86%
Yield on Cost 5y 4.12%
Annual Growth 5y 9.66%
Payout Consistency 75.5%

SPTS Growth Ratios

Growth Correlation 3m 14%
Growth Correlation 12m 91.7%
Growth Correlation 5y 0.6%
CAGR 5y 1.31%
CAGR/Mean DD 5y 0.89
Sharpe Ratio 12m -0.37
Alpha -0.75
Beta 0.01
Volatility 1.39%
Current Volume 836.4k
Average Volume 20d 1089.8k
What is the price of SPTS stocks?
As of December 27, 2024, the stock is trading at USD 28.91 with a total of 836,426 shares traded.
Over the past week, the price has changed by +0.10%, over one month by +0.27%, over three months by -0.25% and over the past year by +3.99%.
Is SPDR Barclays Short Term a good stock to buy?
Neither. Based on ValueRay Analyses, SPDR Barclays Short Term is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.74 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SPTS as of December 2024 is 27.49. This means that SPTS is currently overvalued and has a potential downside of -4.91%.
Is SPTS a buy, sell or hold?
SPDR Barclays Short Term has no consensus analysts rating.
What are the forecast for SPTS stock price target?
According to ValueRays Forecast Model, SPTS SPDR Barclays Short Term will be worth about 29.7 in December 2025. The stock is currently trading at 28.91. This means that the stock has a potential upside of +2.66%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.7 2.7%